1. Mao, Haiyan, Xu, Yuan, Zhang, Zhengrong, Liu, Siping, Bo, Ping. 2020. Biliverdin Reductase A (BLVRA) Promotes Colorectal Cancer Cell Progression by Activating the Wnt/β-Catenin Signaling Pathway. In Cancer management and research, 12, 2697-2709. doi:10.2147/CMAR.S242531. https://pubmed.ncbi.nlm.nih.gov/32425592/
2. Sun, Ling, Zhang, Jie, Chen, Wenfeng, Huang, Kun, Yang, Yufeng. 2020. Attenuation of epigenetic regulator SMARCA4 and ERK-ETS signaling suppresses aging-related dopaminergic degeneration. In Aging cell, 19, e13210. doi:10.1111/acel.13210. https://pubmed.ncbi.nlm.nih.gov/32749068/
3. Li, Yongpei, Wu, Ting, Chen, Ling, Zhu, Yunxia. 2019. Associations between G6PD, OATP1B1 and BLVRA variants and susceptibility to neonatal hyperbilirubinaemia in a Chinese Han population. In Journal of paediatrics and child health, 55, 1077-1083. doi:10.1111/jpc.14346. https://pubmed.ncbi.nlm.nih.gov/30636082/
4. Chen, Xinju, Yang, Fangming, Zhang, Chuanlei, Chen, Xiaoqi, Zhao, Wenxia. 2024. BLVRA exerts its biological effects to induce malignant properties of hepatocellular carcinoma cells via Wnt/β-catenin pathway. In Journal of molecular histology, 55, 159-167. doi:10.1007/s10735-023-10179-w. https://pubmed.ncbi.nlm.nih.gov/38216836/